Halozyme Therapeutics
HALO
#2478
Rank
A$8.98 B
Marketcap
$70.62
Share price
-15.40%
Change (1 day)
15.63%
Change (1 year)

Halozyme Therapeutics (HALO) - Net assets

Net assets on the balance sheet as of September 2024 : A$0.70 Billion

According to Halozyme Therapeutics's latest financial reports the company has A$0.70 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Halozyme Therapeutics - Net assets on balance sheet (from 2002 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$A$0.12 B-50.7%
2022-12-31$A$0.24 B-8.15%
2021-12-31$A$0.27 B38.3%
2020-12-31$A$0.19 B49.88%
2019-12-31$A$0.13 B-62.9%
2018-12-31$A$0.35 B32.37%
2017-12-31$A$0.26 B-692.3%
2016-12-31$-A$45.07 Million-176.34%
2015-12-31$A$59.02 M16.82%
2014-12-31$A$50.52 M-325.46%
2013-12-31$-A$22.42 Million-147.67%
2012-12-31$A$47.01 M342.22%
2011-12-31$A$10.63 M-46.94%
2010-12-31$A$20.03 M160.71%
2009-12-31$A$7.68 M-64.75%
2008-12-31$A$21.79 M-67.01%
2007-12-31$A$66.07 M125.67%
2006-12-31$A$29.27 M17.67%
2005-12-31$A$24.88 M29.89%
2004-12-31$A$19.15 M3709.19%
2003-12-31$A$0.5 M-174.65%
2002-12-31$-A$0.68 Million-1605.48%
2001-12-31$A$0.04 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
-A$0.35 Billion-149.87%๐Ÿ‡บ๐Ÿ‡ธ USA
A$22.15 B 3,063.38%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.92 B 1,602.66%๐Ÿ‡บ๐Ÿ‡ธ USA
A$143.18 B 20,345.63%๐Ÿ‡บ๐Ÿ‡ธ USA
A$121.05 B 17,185.42%๐Ÿ‡ซ๐Ÿ‡ท France
A$108.53 B 15,397.58%๐Ÿ‡บ๐Ÿ‡ธ USA